Related Experiment Video
Updated: Feb 4, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Chromium picolinate reduces morphine-dependence in rats, while increasing brain serotonin levels
Diana Ciubotariu1, Mihai Nechifor1, Gabriel Dimitriu2
1Pharmacology and Clinical Pharmacology Department, University of Medicine and Pharmacy "Gr. T. Popa", Iaşi, Romania.
Chromium picolinate (CrPi) supplementation in rats led to a significant reduction in morphine dependence and withdrawal symptoms. This effect was associated with increased brain serotonin levels, supporting chromium's potential antidepressant properties.
Area of Science:
- Neuroscience
- Pharmacology
- Nutritional Science
Background:
- Chromium is an essential trace element known for its anti-diabetic and anti-depressant effects.
- Chromium's antidepressant properties are linked to its ability to increase brain serotonin levels.
- Previous research indicated Cr3+ salts can enhance rewarding effects, but its impact on addiction processes remained unexplored.
Purpose of the Study:
- To investigate the influence of chromium picolinate (CrPi) on morphine dependence in a rat model.
- To assess whether CrPi can mitigate the development or expression of morphine dependence.
Main Methods:
- Five groups of rats were used, with control groups receiving saline or CrPi.
- Morphine dependence was induced over 10 days with progressively increasing doses.
- Two groups received CrPi (5 and 10 μg/kg/day) during dependence induction.
- Withdrawal symptoms were precipitated by naloxone administration and withdrawal scores were compared.
- Brain serotonin levels and serum chromium were measured post-experiment.
Main Results:
- Chromium picolinate (CrPi) significantly reduced compulsive mastication, teeth chattering, and grooming behaviors associated with morphine withdrawal.
- Both low and high doses of CrPi decreased the overall withdrawal score.
- CrPi administration led to increased brain serotonin (5-HT) levels, particularly in the prefrontal cortex.
- Serum chromium levels increased dose-dependently following CrPi administration.
Conclusions:
- Chromium picolinate (CrPi) demonstrated a significant, albeit modest, reduction in morphine dependence and withdrawal symptoms in rats.
- The observed effects are correlated with increased brain serotonin levels, suggesting a serotonin-mediated mechanism.
- These findings provide supplementary evidence for chromium's antidepressant effects and its potential role in modulating addiction-related pathways.
More Related Videos
07:27Two-photon Imaging of Microglial Processes' Attraction Toward ATP or Serotonin in Acute Brain Slices
Published on: January 31, 2019
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Increasing Function
Frequency-dependent Selection
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Increased Body Temperature